10x Genomics Inc - Ordinary Shares - Class A

NASDAQ:TXG   3:59:56 PM EDT
140.86
+4.71 (+3.46%)
Earnings Announcements

10X Genomics Reports Qtrly Loss Per Share Of 65 Cents

Published: 11/10/2020 21:18 GMT
10x Genomics, Inc. (TXG) - 10x Genomics Reports Third Quarter 2020 Financial Results.
Q3 Revenue $71.8 Million Versus Refinitiv Ibes Estimate of $61.2 Million.
Qtrly Loss per Share 65 Cents.
Revenue is expected to be $100.43 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $103.16 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.